GSA Capital Partners LLP Takes Position in HCA Healthcare, Inc. $HCA

Key Points

• GSA Capital Partners acquired 2,459 shares of HCA Healthcare during the second quarter, worth approximately $959,000. Institutional investors collectively own 62.73% of the company.
• HCA reported quarterly earnings of $7.59 per share and revenue of $20.23 billion, exceeding analyst estimates; revenue increased 8.7% year over year.
• The company declared a quarterly dividend of $0.78 per share, equating to an annualized dividend of $3.12 and a 0.8% yield. Analysts maintain a consensus “Moderate Buy” rating with an average price target of $465.59.

GSA Capital Partners LLP bought a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,459 shares of the company's stock, valued at approximately $959,000.

A number of other institutional investors have also recently added to or reduced their stakes in HCA. Palisade Asset Management LLC acquired a new position in shares of HCA Healthcare during the third quarter valued at $26,000. Ares Financial Consulting LLC acquired a new position in HCA Healthcare during the 4th quarter valued at about $31,000. Cedar Mountain Advisors LLC bought a new stake in shares of HCA Healthcare during the first quarter valued at approximately $33,000. MCF Advisors LLC grew its holdings in HCA Healthcare by 213.0% in the 4th quarter. MCF Advisors LLC now owns 72 shares of the company's stock worth $34,000 after buying an additional 49 shares in the last quarter. Finally, Clearstead Trust LLC bought a new position in shares of HCA Healthcare in the second quarter worth $29,000. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $412.27 on Wednesday. The stock has a market capitalization of $89.26 billion, a price-to-earnings ratio of 13.80, a PEG ratio of 1.40 and a beta of 1.10. HCA Healthcare, Inc. has a 1-year low of $353.99 and a 1-year high of $556.52. The company has a 50 day moving average price of $395.07 and a 200 day moving average price of $445.35.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating analysts' consensus estimates of $7.56 by $0.03. The company had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company's quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.84 EPS. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 29.47 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare's payout ratio is presently 10.45%.

Wall Street Analyst Weigh In

HCA has been the subject of several research analyst reports. Leerink Partners reduced their price objective on shares of HCA Healthcare from $573.00 to $500.00 and set an "outperform" rating for the company in a report on Monday, April 27th. Raymond James Financial set a $528.00 price target on shares of HCA Healthcare in a research note on Tuesday, July 7th. UBS Group dropped their target price on HCA Healthcare from $635.00 to $579.00 and set a "buy" rating on the stock in a report on Monday, July 27th. JPMorgan Chase & Co. lowered their price target on HCA Healthcare from $535.00 to $490.00 and set a "neutral" rating on the stock in a research report on Tuesday, May 19th. Finally, Sanford C. Bernstein reaffirmed a "market perform" rating on shares of HCA Healthcare in a research note on Wednesday, July 15th. Fourteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $465.59.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source